TNSN96069A1 - Un procede pour la preparation de l'hydrochlorure de lercanidipine - Google Patents
Un procede pour la preparation de l'hydrochlorure de lercanidipineInfo
- Publication number
- TNSN96069A1 TNSN96069A1 TNTNSN96069A TNSN96069A TNSN96069A1 TN SN96069 A1 TNSN96069 A1 TN SN96069A1 TN TNSN96069 A TNTNSN96069 A TN TNSN96069A TN SN96069 A TNSN96069 A TN SN96069A TN SN96069 A1 TNSN96069 A1 TN SN96069A1
- Authority
- TN
- Tunisia
- Prior art keywords
- dimethyl
- preparation
- diphenylpropyl
- nitrophenyl
- lercanidipine hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
UN PROCEDE POUR LA PREPARATION DE METHYLE-1, 1-N-TRIMETHYL-N-(3, 3-DIPHENYLPROPYL)-2-AMINOETHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL) -PYRIDINE-3,5-DICARBOXYLATE (LERCANIDIPINE) OU L'ON MET EN REACTION UN HALOGENURE ACIDE DE L'ACIDE 2,6-DIMETHYL-5-METHOXYCARBONYL-4-(3- NITROPHENYL)-1,4-DIHYDROPYRIDINE-3-CARBOXY LIQUE AVEC DU 2, N-DIMETHYL-N- (3,3-DIPHENYLPROPYL)-1-AMINO-2-PROPANOL DANS UN SOLVANT APROTIQUE. LE PRODUIT PEUT ETRE ISOLE PAR DES TECHNIQUES DE CRISTALLISATION INDUSTRIELLEMENT APPLICABLES ET EST OBTENU A UN RENDEMENT ELEVE SOUS LA FORME DE SON HYDROCHLORURE ANHYDRE, UNE FORME QUE PRESENTE UNE STABILITE ELEVEE ET UNE BASSE HYGROSCOPICITE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI950957A IT1274480B (it) | 1995-05-12 | 1995-05-12 | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN96069A1 true TNSN96069A1 (fr) | 2005-03-15 |
Family
ID=11371581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN96069A TNSN96069A1 (fr) | 1995-05-12 | 1996-05-10 | Un procede pour la preparation de l'hydrochlorure de lercanidipine |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP0824517B1 (fr) |
| JP (1) | JP4038622B2 (fr) |
| KR (1) | KR100395441B1 (fr) |
| CN (1) | CN1101810C (fr) |
| AR (1) | AR002739A1 (fr) |
| AT (1) | ATE221050T1 (fr) |
| AU (1) | AU694046B2 (fr) |
| BG (1) | BG62400B1 (fr) |
| BR (1) | BR9608374A (fr) |
| CA (1) | CA2217849C (fr) |
| CZ (1) | CZ288634B6 (fr) |
| DE (1) | DE69622552T2 (fr) |
| DK (1) | DK0824517T3 (fr) |
| DZ (1) | DZ2032A1 (fr) |
| EA (1) | EA000346B1 (fr) |
| EE (1) | EE03351B1 (fr) |
| EG (1) | EG21755A (fr) |
| ES (1) | ES2179942T3 (fr) |
| HU (1) | HU226709B1 (fr) |
| IL (1) | IL118143A (fr) |
| IN (1) | IN188486B (fr) |
| IT (1) | IT1274480B (fr) |
| MA (1) | MA23858A1 (fr) |
| MX (1) | MX9708662A (fr) |
| MY (1) | MY113802A (fr) |
| NO (1) | NO309423B1 (fr) |
| NZ (1) | NZ309059A (fr) |
| PL (1) | PL185260B1 (fr) |
| PT (1) | PT824517E (fr) |
| RO (1) | RO119616B1 (fr) |
| SA (1) | SA96170216B1 (fr) |
| SK (1) | SK283321B6 (fr) |
| TN (1) | TNSN96069A1 (fr) |
| TW (1) | TW404940B (fr) |
| UA (1) | UA46769C2 (fr) |
| WO (1) | WO1996035668A1 (fr) |
| ZA (1) | ZA963716B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| EP1553941A1 (fr) * | 2002-10-16 | 2005-07-20 | Recordati Ireland Limited | Polytherapie a base de lisinopril/lercanidipine |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR100713136B1 (ko) * | 2005-05-04 | 2007-05-02 | 주식회사 대희화학 | 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법 |
| ATE445602T1 (de) * | 2005-06-15 | 2009-10-15 | Hetero Drugs Ltd | Neues verfahren zur herstellung von lercanidipin |
| RU2425033C2 (ru) | 2005-09-16 | 2011-07-27 | Гленмарк Фармасьютикалз Лимитед | Полиморфная форма гидрохлорида лерканидипина и способ ее получения |
| KR100811497B1 (ko) * | 2005-10-19 | 2008-03-07 | 신풍제약주식회사 | 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법 |
| EP1860102B1 (fr) * | 2006-05-24 | 2008-11-26 | CF Pharma Ltd. | Procédé pour la Preparation de Lercanipidine |
| KR100808281B1 (ko) * | 2006-06-30 | 2008-03-03 | 주식회사 하원정밀화학 | 레르카니디핀 및 그 산부가염의 제조방법 |
| CN102020602B (zh) * | 2009-09-18 | 2013-12-25 | 深圳信立泰药业股份有限公司 | 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物 |
| SI2585051T2 (sl) | 2010-06-23 | 2020-07-31 | Krka, D.D., Novo Mesto | Farmacevtske oralne odmerne oblike,ki obsegajo lerkanidipin in enalapril in njune farmacevtsko sprejemljive soli |
| WO2012085249A2 (fr) | 2010-12-24 | 2012-06-28 | Krka, D.D., Novo Mesto | Formes pharmaceutiques orales homogènes comprenant de la lercanidipine et de l'énalapril ou leurs sels pharmaceutiquement acceptables |
| CN102516160B (zh) * | 2011-12-16 | 2014-04-02 | 华润赛科药业有限责任公司 | 一种高纯盐酸乐卡地平的合成工艺 |
| CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
| CN102584682A (zh) * | 2011-12-31 | 2012-07-18 | 苏州二叶制药有限公司 | 盐酸乐卡地平的制备方法 |
| CN109956943B (zh) * | 2019-04-18 | 2021-07-20 | 合肥合源药业有限公司 | 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-05-12 IT ITMI950957A patent/IT1274480B/it active IP Right Grant
-
1996
- 1996-05-03 IL IL11814396A patent/IL118143A/en not_active IP Right Cessation
- 1996-05-06 IN IN822CA1996 patent/IN188486B/en unknown
- 1996-05-07 MA MA24223A patent/MA23858A1/fr unknown
- 1996-05-08 DZ DZ960075A patent/DZ2032A1/fr active
- 1996-05-09 SK SK1514-97A patent/SK283321B6/sk not_active IP Right Cessation
- 1996-05-09 MY MYPI96001751A patent/MY113802A/en unknown
- 1996-05-09 CN CN96193842A patent/CN1101810C/zh not_active Expired - Lifetime
- 1996-05-09 AU AU58985/96A patent/AU694046B2/en not_active Expired
- 1996-05-09 PL PL96323236A patent/PL185260B1/pl unknown
- 1996-05-09 ES ES96916111T patent/ES2179942T3/es not_active Expired - Lifetime
- 1996-05-09 EE EE9700303A patent/EE03351B1/xx unknown
- 1996-05-09 HU HU9801913A patent/HU226709B1/hu unknown
- 1996-05-09 DE DE69622552T patent/DE69622552T2/de not_active Expired - Lifetime
- 1996-05-09 CA CA002217849A patent/CA2217849C/fr not_active Expired - Lifetime
- 1996-05-09 EG EG40296A patent/EG21755A/xx active
- 1996-05-09 BR BR9608374A patent/BR9608374A/pt not_active Application Discontinuation
- 1996-05-09 EA EA199700374A patent/EA000346B1/ru not_active IP Right Cessation
- 1996-05-09 UA UA97125981A patent/UA46769C2/uk unknown
- 1996-05-09 NZ NZ309059A patent/NZ309059A/xx not_active IP Right Cessation
- 1996-05-09 AT AT96916111T patent/ATE221050T1/de active
- 1996-05-09 JP JP53379796A patent/JP4038622B2/ja not_active Expired - Lifetime
- 1996-05-09 KR KR1019970707905A patent/KR100395441B1/ko not_active IP Right Cessation
- 1996-05-09 RO RO97-02101A patent/RO119616B1/ro unknown
- 1996-05-09 CZ CZ19973567A patent/CZ288634B6/cs not_active IP Right Cessation
- 1996-05-09 WO PCT/EP1996/002122 patent/WO1996035668A1/fr active IP Right Grant
- 1996-05-09 DK DK96916111T patent/DK0824517T3/da active
- 1996-05-09 PT PT96916111T patent/PT824517E/pt unknown
- 1996-05-09 EP EP96916111A patent/EP0824517B1/fr not_active Expired - Lifetime
- 1996-05-10 TN TNTNSN96069A patent/TNSN96069A1/fr unknown
- 1996-05-10 TW TW085105567A patent/TW404940B/zh not_active IP Right Cessation
- 1996-05-10 AR ARP960102528A patent/AR002739A1/es unknown
- 1996-05-10 ZA ZA963716A patent/ZA963716B/xx unknown
- 1996-08-07 SA SA96170216A patent/SA96170216B1/ar unknown
-
1997
- 1997-11-07 BG BG102034A patent/BG62400B1/bg unknown
- 1997-11-11 MX MX9708662A patent/MX9708662A/es unknown
- 1997-11-11 NO NO975176A patent/NO309423B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN96069A1 (fr) | Un procede pour la preparation de l'hydrochlorure de lercanidipine | |
| NO963991L (no) | Fremgangsmåte ved separasjon av enantiomerer av amlodipin via deres diastereomere tartrater | |
| DE69738154T2 (de) | Optische auflösung von methylphenidat mittels 0,0'-bisaroyl-weinsäuren | |
| BRPI0009229B8 (pt) | processo de purificação de ácido láctico, em escala industrial. | |
| KR960037682A (ko) | 축합 6환 화합물 및 그의 제조방법 | |
| DE10299006I1 (de) | 8-Alkoxychinolincarbonsaeure und Salze davon die sich durch selektive Toxizitaet auszeichnen und Verfahren zu ihrer Herstellung | |
| ATE150456T1 (de) | Verfahren zur herstellung von an 4-position substituierten 1,4-dihydropyridinen | |
| KR840006644A (ko) | 1,4-디히드로피리딘 유도체 및 그제법 | |
| US5942624A (en) | Manufacturing process for felodipine | |
| US4845272A (en) | Process for the optical resolution of (±)-cis or (±)-trans-permethric acid | |
| EP0398417B1 (fr) | Préparation d'hydroxyfurannone | |
| UA27719C2 (uk) | Ефіри 2,6-диметил-1,4-дигідропіридин-3-карбонової кислоти, що є блокаторами кальцієвих каналів, спосіб їх одержання та фармацевтична композиція | |
| BE1003199A5 (fr) | Procede de preparation des derives de 1,4-dihydropyridine et a de nouveaux intermediaires utiles pour cette preparation. | |
| ATE213492T1 (de) | Verfahren zur herstellung von racemisch sertralin | |
| KR930016399A (ko) | 특정 1,4-디히드로피리딘-3,5-디카르복실산 에스테르, 그의 제조 방법 및 그의 제약 용도 | |
| IT1318508B1 (it) | Processo per la separazione di 2,6-dimetilnaftalene da miscele che locontengono. | |
| CO5040220A1 (es) | Un procedimiento para la preparacion de clorhidrato de lercanidipino | |
| BE877311A (fr) | Procede pour la preparation du 2,6-dimethyl-4-(3-nitrophenyl)-3-methoxycarbonyl-1, 4-dihydropyridine-5-carboxylate de 2-(n-benzyl-n-methylamino) ethyle | |
| SU1564168A1 (ru) | Способ получени концентрированного раствора катионного индоленинового красител | |
| KR970042532A (ko) | 광학 활성 3-히드록시-1,5-벤조티아제핀 유도체 및 이것의 중간체의 제조 방법 | |
| DE69006210D1 (de) | Verfahren zur abscheidung von distickstoffpentoxyd aus seiner lösung in salpetersäure. | |
| ATE126190T1 (de) | 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5- | |
| Raev et al. | Competitive reactions in the synthesis of nitrendipine | |
| TH18940B (th) | กรรมวิธีสำหรับการเตรียม กรด (l) หรือ (d)-โฮโมอะลานิน 4-อิล (เมธิล) ฟอสฟินิกและเกลือของกรดนั้นโดยการแยกสารผสมเรซิเมท | |
| JPS62289564A (ja) | ２−（ｎ−ベンジル−ｎ−メチルアミノ）エチル・メチル・１，４−ジヒドロ−２，６−ジメチル−４−（３−ニトロフェニル）−３，５−ピリジン−ジカルボキシレ−ト・ハイドロクロライドの製造方法 |